Glecaprevir/Pibrentasvir and Rosuvastatin Interaction

Drug interaction information between Glecaprevir/Pibrentasvir and Rosuvastatin.

Glecaprevir/Pibrentasvir and Rosuvastatin have a documented major interaction in FDA labeling.

FDA drug labeling documents a major-severity interaction between Glecaprevir/Pibrentasvir and Rosuvastatin. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Glecaprevir/Pibrentasvir

NS3/4A/NS5A Inhibitor (HCV)

Drug B

Rosuvastatin

HMG-CoA Reductase Inhibitor (Statin)

How They Interact

These drugs can cause rosuvastatin levels to rise in your body, which may increase the risk of side effects.

FDA Label Information

Simeprevir Dasabuvir/ombitasvir/paritaprevir/ritonavir Elbasvir/grazoprevir Sofosbuvir/velpatasvir Glecaprevir/pibrentasvir Atazanavir/ritonavir Lopinavir/ritonavir Initiate with rosuvastatin 5 mg once daily, and do not exceed a dose of rosuvastatin 10 mg once daily.

Frequently Asked Questions

What SPL severity band is on file for Glecaprevir/Pibrentasvir + Rosuvastatin?

Compiled FDA labeling labels this pair major. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Glecaprevir/Pibrentasvir has 38 labeled pairs on file vs Rosuvastatin's 21. In the major band specifically: Glecaprevir/Pibrentasvir has 3 (also Rifampin, Rosuvastatin/Ezetimibe); Rosuvastatin has 3 (also Sofosbuvir/Velpatasvir, Febuxostat).

What mechanism field is on file for Glecaprevir/Pibrentasvir and Rosuvastatin?

These drugs can cause rosuvastatin levels to rise in your body, which may increase the risk of side effects.

Glecaprevir/Pibrentasvir's labeled portfolio outnumbers Rosuvastatin

SPL source-record counts only. This page's band is major · classes on file: Glecaprevir/Pibrentasvir (NS3/4A/NS5A Inhibitor (HCV)); Rosuvastatin (HMG-CoA Reductase Inhibitor (Statin)).

Glecaprevir/Pibrentasvir

3 major · 9 moderate · 26 minor · 38 total

Rosuvastatin

3 major · 8 moderate · 10 minor · 21 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.